GEMI

Gemini Space Station, Inc. Financials Finance Services Russell 3000
$2.87Close $2.87 – $18.3552-week range Nov 12, 2026Next report · after the close

Highlights

Cautions

  • Not in an uptrend 0 of 8 trend conditions
  • Lagging the market RS 2 · weaker than 98% of stocks over 12 months
  • Far from its high 84% below its 52-week high
  • Results soon Nov 12, 2026, in 11 days
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 13, 2026
Off 12-month high 84%
1wk down 6.2% price change
1mo down 44.4% price change
12-month return down 84% market up 11% · its own down 96%
F-score — — Not assessed
Altman Z″ -3.20 Elevated risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B — price / book
Earnings yield — EBIT / enterprise value
Cheaper than — of the market · not assessed
Revenue growth up 26% year on year
EPS growth — latest quarter
Sales growth up 37% latest quarter · -6 pts
ROE down 108% return on equity
Free cash margin —
D/E — long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest

Trade setup

ATR% 10.3% $0.30 a day · 2×ATR $2.28
RS 2 / 99 vs the universe
Trend 0 / 8 trend template
Relative volume 0.6× vs 50-day average
Up/down volume 0.93 50 sessions
Implied move — no option chain · report Nov 12, 2026
Trend template · 0 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
Last reported Aug 13, 2026
Results reaction Aug 13, 2026-6% vs market2 sessions after results

Financials

3 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $179.6M +26% on FY2024
$0 $200M FY23 FY24 FY25 FY2023 · $98.1M FY2024 · $142.2M FY2025 · $179.6M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$582.8M
-$1B $0 FY23 FY24 FY25 FY2023 · -$319.7M FY2024 · -$158.5M FY2025 · -$582.8M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net -325%
-500% 0% FY23 FY24 FY25 FY2023 · Net -326% FY2024 · Net -112% FY2025 · Net -325%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $500M FY23 FY24 FY25 FY2023 · Cash $32.8M FY2024 · Cash $42.8M FY2025 · Cash $252.2M
  FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $98.1M $142.2M $179.6M
Operating income -$311.6M -$165.8M -$345.7M
Net income -$319.7M -$158.5M -$582.8M
Net margin -326% -112% -325%
Earnings per share -$66.25 -$32.24 -$15.52
Cash $32.8M $42.8M $252.2M
Shareholders' equity -$644.3M -$795.4M $540.9M

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 13, 2026 Quarterly ↗ Jun 30, 2026 44d
May 15, 2026 Quarterly ↗ Mar 31, 2026 45d
Mar 31, 2026 Annual ↗ Dec 31, 2025 90d
Nov 10, 2025 Quarterly ↗ Sep 30, 2025 41d

Current reports